Predicting pancreatic leak after pancreatic surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial looks at factors that can predict a serious complication called a pancreatic fistula (a leak from the pancreas) after a Whipple procedure. The goal is to help doctors better understand and manage this risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a Whipple procedure to remove a tumor in the pancreas, bile duct, duodenum, or area near the pancreas.
- The surgery is meant to cure your cancer, with no signs of spread to other organs.
- You are in good enough health for major surgery (rated as ASA I or II).
- You are 18 years or older.
- You agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests injecting a medical glue into the pancreas during a Whipple procedure to see if it can prevent leaks. It may help people with a soft pancreas and small pancreatic duct.
This trial compares two ways of reconnecting the pancreas after a Whipple surgery for cancer. It tests whether using a special surgical glue (Glubran2) helps reduce leaks and improve healing.
This trial tests whether a special medical glue (Glubran® 2) applied to the pancreas during surgery can help prevent fluid leaks. It is for people undergoing a Whipple procedure for pancreatic cancer who have a soft pancreas.
This study tests whether washing the belly with fluid during surgery can lower the chance of a leak from the pancreas after a Whipple operation. If you are having this surgery for a tumor in the pancreas, bile duct, or nearby area, this trial may help reduce a common complication.
This trial tests if a short course of radiation before surgery can lower the risk of a pancreatic leak (a common complication). It is for people who are overweight, older than 45, and have a small pancreatic duct.
This Phase 3 trial studies a pancreatic surgery approach (pylorus-preserving Whipple or similar) and, in some cases, moving your insulin-making cells into your body to help prevent a dangerous post-surgery leak from the pancreas. It may help people who are considered high risk for this complication based on pancreas texture and duct size.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.